S. Morry Blumenfeld

S. Morry Blumenfeld has a diverse work experience in various companies and roles. S. Morry started as the CEO of Quescon Consultants in 2012 and became the Chairman of the Advisory Board at Nanox Imaging the same year. In 2013, they joined illumigyn as the Director and Chairman of the Scientific Advisory Board.

Blumenfeld further expanded their expertise in the medical field by becoming the Chief Investment Officer at Meditech Advisors, LLC and Meditech Advisors Management, LLC in 2003. S. Morry also took on the role of Director at Aposense in 2007.

In 2014, they took on multiple director positions, including at Sight Diagnostics, Ltd and InSightec, where they served until 2021 and 2021, respectively. At OurCrowd, they became a Venture Partner and Chairman of the Medical Advisory Board in 2014. S. Morry also served as a Director at Cardiologic Innovations from 2015 to 2018.

Blumenfeld's most recent role is as a Director at Alpha Tau Medical, starting in 2016. These experiences demonstrate their extensive involvement in various healthcare and medical device companies, showcasing their expertise and leadership in the industry.

S. Morry Blumenfeld completed their education from 1956 to 1967 at the University of Toronto. S. Morry obtained degrees in Engineering Physics, Molecular Physics (BASc, MA, PhD) and Physics (Bachelor of Applied Science, MA, PhD).